Biological Rejuvenation of Higher Animals and Humans

Ideas&Problem Solving
Start-Ups&Venture Funds,
Inventors&Investors,
Promotion etc.

Biological Rejuvenation of Higher Animals and Humans

Postby Administrator » Tue Nov 08, 2011 11:19 am

Technology: Company offers a principally new method of human rejuvenation by renewal of connective tissue : the internal environment of the human body cells.
The method include two applications:
▼ The general biological rejuvenation of human body by an intravenous injection of the new mixture of enzymes and biological active factors that stimulate the replacement of the old connective tissue proteins (basically collagen) by the new young ones.
▼ The local biological rejuvenation of human skin by a new composite enzymatic rejuvenated agent (Cream/Gel or water solution). This agent leads to the destruction of the old intercellular proteins (collagen and proteoglicans) and their replacement by the new young once.

The Company has performed the first stage of the study - pre-clinical animal experiments. The action of the agent that destroys old collagen on the important index rejuvenation effect and increase the oxygen consumption, was verified. Therefore, the first stage of experimental testing demonstrate the positive results and is promising for capability of the artificially rejuvenation effect.
The company is looking for investments for the completion of animal stage study on general rejuvenation and skin rejuvenation as well. For contact click here.
Administrator
Site Admin
 
Posts: 16
Joined: Tue Sep 13, 2011 2:07 pm

Re: Biological Rejuvenation of Higher Animals and Humans

Postby Gadi » Fri Nov 11, 2011 1:07 pm

What is the global market for anti-aging products today?
Gadi
 

Re: Biological Rejuvenation of Higher Animals and Humans

Postby Administrator » Fri Nov 11, 2011 1:39 pm

The global market for anti-aging products and services was worth $162.2 billion in 2008. This will increase to $274,5 billion in 2013, for a compound annual growth rate (CAGR) of 11% [according to a BCC Research, http://www.BCCResearch.com]. Our segment of the market has the second largest share, worth $64.4 billion in 2008. This segment is expected to generate $105.4 billion in 2013, for a CAGR of 10.4 percent.
Administrator
Site Admin
 
Posts: 16
Joined: Tue Sep 13, 2011 2:07 pm


Return to Advanced Bio-Medical Technologies and Projects

Who is online

Users browsing this forum: No registered users and 1 guest

cron